Magna Investama Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Magna Investama Mandiri Tbk. trades at Rp91 (market cap 310.41B, 614.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Magna Investama Mandiri Tbk. is the larger of the two by market cap, and Magna Investama Mandiri Tbk. is more actively traded (614.3K versus 96.7K). Which is the better fit depends on your goals.
| MGNA | OBAT | |
|---|---|---|
Market Cap | 310.41B | 167.37B |
Volume | 614.3K | 96.7K |
Lot | 6.14K | 967 |
Turnover | 56M | 23.82M |
Average Price | 91.16 | 246.34 |
Value | 56M | 23.82M |
Indicative Equilibrium Price | 91 | 248 |
Indicative Equilibrium Volume | 75 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Read more on MGNA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →